NEWARK, Del, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The cutting balloons market was estimated at US$ 400.2 million in 2022, and by 2033, it is anticipated to be worth US$ 725.9 million. With a value share ...

In pediatric patients considered “untreatable” after failing low-pressure balloon angioplasty for pulmonary artery stenosis, treatment with a cutting balloon is more effective than high-pressure ...

Wilmington, Delaware, United States, March 24, 2023 (GLOBE NEWSWIRE) -- According to recent study by Transparency Market Research, the global cutting angioplasty balloons market is projected to expand ...

Washington, DC - As Cutting Balloon TM (Boston Scientific, Natick, MA) angioplasty has struggled to find a niche in the world of interventional cardiologyespecially in light of two previous randomized ...

Please provide your email address to receive an email when new articles are posted on . Results of a small study suggest that cutting balloon angioplasty is safe and efficacious for the routine ...

Washington, DC - The Cutting Balloon TM (Boston Scientific) has tenaciously held on to a limited role in interventional cardiology throughout years of uncertainty about its value. After it failed ...

Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) angioplasty to intravascular lithotripsy (IVL) prior to drug-eluting stent (DES) ...

In September 2022, Lepu Medical Technology (Beijing) Co., Ltd. was given marketing approval for its Vesscide peripheral cutting balloon by China's National Medical Products Administration, which is ...

Pelviureteric junction (PUJ) obstruction is a congenital or acquired stenosis of the junction between the renal pelvis and the ureter, which inhibits normal urine flow. It can cause chronic or ...

2.1.1 Pelviureteric junction obstruction is a congenital or acquired stenosis of the junction between the renal pelvis and the ureter, which inhibits normal urine flow. It can cause chronic or ...